110 related articles for article (PubMed ID: 36243107)
1. Generation of good manufacturing practice grade virus-specific T cells for the management of post-transplant CMV infections.
Arunachalam AK; Palani HK; Yasar M; Kulkarni U; Mathews V; George B
J Immunol Methods; 2022 Dec; 511():113375. PubMed ID: 36243107
[TBL] [Abstract][Full Text] [Related]
2. A single exercise bout enhances the manufacture of viral-specific T-cells from healthy donors: implications for allogeneic adoptive transfer immunotherapy.
Spielmann G; Bollard CM; Kunz H; Hanley PJ; Simpson RJ
Sci Rep; 2016 May; 6():25852. PubMed ID: 27181409
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a Cytomegalovirus-Specific T Lymphocyte Product Obtained Through a Rapid and Scalable Production Process for Use in Adoptive Immunotherapy.
Grau-Vorster M; López-Montañés M; Cantó E; Vives J; Oliver-Vila I; Barba P; Querol S; Rudilla F
Front Immunol; 2020; 11():271. PubMed ID: 32161589
[TBL] [Abstract][Full Text] [Related]
4. The effects of β
Kunz HE; Agha NH; Hussain M; LaVoy EC; Smith KA; Mylabathula P; Diak D; Baker FL; O'Connor DP; Bond RA; Katsanis E; Bollard CM; Simpson RJ
Cell Stress Chaperones; 2020 Nov; 25(6):993-1012. PubMed ID: 32779001
[TBL] [Abstract][Full Text] [Related]
5. Antigenic competition in the generation of multi-virus-specific cell lines for immunotherapy of human cytomegalovirus, polyomavirus BK, Epstein-Barr virus and adenovirus infection in haematopoietic stem cell transplant recipients.
Roubalová K; Němečková Š; Kryštofová J; Hainz P; Pumannová M; Hamšíková E
Immunol Lett; 2020 Dec; 228():64-69. PubMed ID: 33031870
[TBL] [Abstract][Full Text] [Related]
6. Identification of new cytokine combinations for antigen-specific T-cell therapy products via a high-throughput multi-parameter assay.
Lazarski CA; Datar AA; Reynolds EK; Keller MD; Bollard CM; Hanley PJ
Cytotherapy; 2021 Jan; 23(1):65-76. PubMed ID: 32921560
[TBL] [Abstract][Full Text] [Related]
7. High-intensity interval training in allogeneic adoptive T-cell immunotherapy - a big HIT?
Heinemann NC; Tischer-Zimmermann S; Wittke TC; Eigendorf J; Kerling A; Framke T; Melk A; Heuft HG; Blasczyk R; Maecker-Kolhoff B; Eiz-Vesper B
J Transl Med; 2020 Apr; 18(1):148. PubMed ID: 32238166
[TBL] [Abstract][Full Text] [Related]
8. Manufacturing of highly functional and specific T cells for adoptive immunotherapy against virus from granulocyte colony-stimulating factor-mobilized donors.
Beloki L; Ramírez N; Olavarría E; Samuel ER; Lowdell MW
Cytotherapy; 2014 Oct; 16(10):1390-408. PubMed ID: 24954783
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of Specific CD4+ and CD8+ T Cells Stimulated by CMV pp65 and IE1 Antigens.
Albiero E; Amati E; Baumeister E; Einsele H; Grigoleit GU; Rodeghiero F
J Immunother; 2016; 39(9):329-342. PubMed ID: 27631893
[TBL] [Abstract][Full Text] [Related]
10. Establishment and Operation of a Third-Party Virus-Specific T Cell Bank within an Allogeneic Stem Cell Transplant Program.
Withers B; Clancy L; Burgess J; Simms R; Brown R; Micklethwaite K; Blyth E; Gottlieb D
Biol Blood Marrow Transplant; 2018 Dec; 24(12):2433-2442. PubMed ID: 30172015
[TBL] [Abstract][Full Text] [Related]
11. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
[TBL] [Abstract][Full Text] [Related]
12. Isolation of highly suppressive CD25+FoxP3+ T regulatory cells from G-CSF-mobilized donors with retention of cytotoxic anti-viral CTLs: application for multi-functional immunotherapy post stem cell transplantation.
Samuel ER; Beloki L; Newton K; Mackinnon S; Lowdell MW
PLoS One; 2014; 9(1):e85911. PubMed ID: 24465783
[TBL] [Abstract][Full Text] [Related]
13. Rapid Generation of TCR and CD8αβ Transgenic Virus Specific T Cells for Immunotherapy of Leukemia.
Bajwa G; Arber C
Front Immunol; 2022; 13():830021. PubMed ID: 35572604
[TBL] [Abstract][Full Text] [Related]
14. Rapid generation of clinical-grade antiviral T cells: selection of suitable T-cell donors and GMP-compliant manufacturing of antiviral T cells.
Tischer S; Priesner C; Heuft HG; Goudeva L; Mende W; Barthold M; Kloeß S; Arseniev L; Aleksandrova K; Maecker-Kolhoff B; Blasczyk R; Koehl U; Eiz-Vesper B
J Transl Med; 2014 Dec; 12():336. PubMed ID: 25510656
[TBL] [Abstract][Full Text] [Related]
15. Large-scale manufacturing and characterization of CMV-CD19CAR T cells.
Wang X; Urak R; Walter M; Guan M; Han T; Vyas V; Chien SH; Gittins B; Clark MC; Mokhtari S; Cardoso A; Diamond DJ; Zaia J; Forman SJ; Nakamura R
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35027426
[TBL] [Abstract][Full Text] [Related]
16. A single exercise bout augments adenovirus-specific T-cell mobilization and function.
Kunz HE; Spielmann G; Agha NH; O'Connor DP; Bollard CM; Simpson RJ
Physiol Behav; 2018 Oct; 194():56-65. PubMed ID: 29723594
[TBL] [Abstract][Full Text] [Related]
17. A phase I-II trial to examine the toxicity of CMV- and EBV-specific cytotoxic T lymphocytes when used for prophylaxis against EBV and CMV disease in recipients of CD34-selected/T cell-depleted stem cell transplants.
Lucas KG; Sun Q; Burton RL; Tilden A; Vaughan WP; Carabasi M; Salzman D; Ship A
Hum Gene Ther; 2000 Jul; 11(10):1453-63. PubMed ID: 10910142
[TBL] [Abstract][Full Text] [Related]
18. [Culture and expansion of CMV-specific T cells derived from peripheral blood stem cells in vitro].
Xia Y; Zhang Z; Li S; Zhan Q; Xiao Q; Wang L; Liu L; Luo X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Jan; 35(1):63-73. PubMed ID: 30914116
[TBL] [Abstract][Full Text] [Related]
19. Rapid generation of CMV pp65-specific T cells for immunotherapy.
Bao L; Sun Q; Lucas KG
J Immunother; 2007; 30(5):557-61. PubMed ID: 17589296
[TBL] [Abstract][Full Text] [Related]
20. Identification of the best-suited donor for generating virus-specific T cells.
Tasnády S; Karászi É; Szederjesi A; Bihari G; Juhász Z; Hardi A; Kriván G; Kállay K; Reményi P; Sinkó J; Mikala G; Réti M; Masszi T
Vox Sang; 2020 Jan; 115(1):18-26. PubMed ID: 31667887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]